Most Active Kidney Care Investors, By Segment

$0+
0 ratings

Welcome to Kidney Capital

This is where great ideas, research, products and teams get funded to build the future of kidney care across the globe. We begin our exploration of the expanding Kidneyverse with a closer look at why, how, and when these ideas get funded— and who is backing them.

What's in this table

  • Who & When: The left-most columns in this table contain 11 of the most active investors in kidney care across the company lifecycle. This group broadly represents four investor types from idea to IPO: (a) accelerators; (b) early stage venture capital; (c) growth equity; and (d) strategic capital.
  • What: There are 4 segments (colors) highlighted in this table: Care delivery (yellow), devices (purple), diagnostics (blue), and other (green). For what it’s worth, I track 9 segments across the Kidneyverse.
  • Why: Investments happen because founders and investors share a unique point of view about what the future looks like. It’s as much about timing (why now?) as it is about fit (why you?). First, I’ve separated investments (solid border lines) from mergers & acquisitions (dotted lines). Second, I’ve included a crown (“👑”) for companies with an exit, either through M&A or IPO.

Signals worth watching in this [space]:

  1. CVS wants to deliver care… everywhere
  2. Baxter is about to make its biggest bet ever
  3. YC is picking up the pace on its bio x health bets
  4. A Tale of Two LDOs: comparing dialysis investments
  5. Public investments work: KidneyX and America’s Seed Fund
  6. Why Oak HC/FT is fueling the future of care delivery
  7. Death Valley: what happens to accelerate-ed MedTech startups?
  8. IPO Cometh: why kidney care will be part of the 2024 IPO window

Access real-time data

Most of my snapshot visuals are free by default to best align with the overall goal of Signals.

If you want access to the data behind these visuals and my work, you can purchase one-time downloads on this site or contact me at trfitzpatrick@substack.com to learn more about licensing real-time data feeds for your business.


About me & signals

I'm Tim Fitzpatrick. By day, I'm building IKONA; by night, I write Signals— curating & sharing lessons from the frontiers of healthcare technology, one [space] at a time. My goal is to make the frontiers of healthcare technology more accessible and actionable for everyone. I do this primarily in two ways, by:

  • Writing and interviewing experts about topics like entrepreneurship, commercialization, leadership, and beyond.
  • Creating visuals to capture and communicate these complex worlds in ways data and deep dives cannot.

Visuals like these are my way of amplifying awareness of the most pressing challenges and promising solutions across healthcare, technology, and society.

$
I want this!

Hi-res, print quality PDF

Size
996 KB
Resolution
1920 x 1750 px
$0+

Most Active Kidney Care Investors, By Segment

0 ratings
I want this!